EUVIMEDEUVIMED entdecken
Editorial

Harmonising Pharmacovigilance and Pharmacoepidemiology: Lessons from Europe for Cohesive Medicines Safety Science

Deborah Layton, Pav Rishiraj

Drug Safety · 18.08.2026

DOI: 10.1007/s40264-026-01713-2 ↗

Kurz gefasst

Editorial in der Zeitschrift Drug Safety, online erschienen am 18.08.2026. Verfasst von Deborah Layton und 1 weiteren Autor:innen. Beteiligte Einrichtung: PEPI Consultancy Limited, 3 Neilson Close, Eastleigh, Hampshire, UK. drdeborahlayton@outlook.com. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • PEPI Consultancy Limited, 3 Neilson Close, Eastleigh, Hampshire, UK. drdeborahlayton@outlook.com.
  • PHARMO, part of Lumanity, Utrecht, The Netherlands. drdeborahlayton@outlook.com.
  • School of Life Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK. drdeborahlayton@outlook.com.
  • Celltrion Healthcare, Uxbridge, Middlesex, UK.

Zitieren

APA

Layton, D., & Rishiraj, P. (2026). Harmonising Pharmacovigilance and Pharmacoepidemiology: Lessons from Europe for Cohesive Medicines Safety Science. Drug Safety. https://doi.org/10.1007/s40264-026-01713-2

Vancouver

Layton D, Rishiraj P. Harmonising Pharmacovigilance and Pharmacoepidemiology: Lessons from Europe for Cohesive Medicines Safety Science. Drug Safety. 2026. doi:10.1007/s40264-026-01713-2

BibTeX
@article{Layton2026,
  author = {Layton, Deborah and Rishiraj, Pav},
  title = {Harmonising Pharmacovigilance and Pharmacoepidemiology: Lessons from Europe for Cohesive Medicines Safety Science},
  journal = {Drug Safety},
  year = {2026},
  doi = {10.1007/s40264-026-01713-2}
}
Kostenlos starten →